Surgery Partners, Inc. Forecast, price target & analysts
Surgery Partners, Inc. Target price 2025 - Analyst rating & recommendation
Surgery Partners, Inc. Classifications & Recommendation:
Surgery Partners, Inc. Price Target
| Target Price | $33.55 |
| Price | $24.62 |
| Potential |
36.25%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Surgery Partners, Inc. 2026 .
The average Surgery Partners, Inc. target price is $33.55.
This is
36.25%
register free of charge
$40.00
62.47%
register free of charge
$28.00
13.73%
register free of charge
|
|
| A rating was issued by 12 analysts: 9 Analysts recommend Surgery Partners, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Surgery Partners, Inc. stock has an average upside potential 2026 of
36.25%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.74 | 3.08 |
| 8.03% | 12.19% | |
| EBITDA Margin | 19.20% | 16.53% |
| 3.95% | 13.89% | |
| Net Margin | -0.42% | -0.84% |
| 85.88% | 101.40% |
11 Analysts have issued a sales forecast Surgery Partners, Inc. 2024 . The average Surgery Partners, Inc. sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Surgery Partners, Inc. EBITDA forecast 2024. The average Surgery Partners, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Surgery Partners, Inc. Analysts have issued a net profit forecast 2024. The average Surgery Partners, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.09 | -0.20 |
| 84.75% | 122.22% | |
| P/E | negative | |
| EV/Sales | 2.62 |
5 Analysts have issued a Surgery Partners, Inc. forecast for earnings per share. The average Surgery Partners, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Surgery Partners, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Surgery Partners, Inc....
Current Surgery Partners, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan | Locked ➜ Locked | Locked | Dec 03 2024 |
| RBC Capital | Locked ➜ Locked | Locked | Nov 20 2024 |
| Macquarie | Locked ➜ Locked | Locked | Nov 19 2024 |
| Macquarie | Locked ➜ Locked | Locked | Nov 13 2024 |
| Macquarie | Locked ➜ Locked | Locked | Nov 04 2024 |
| UBS | Locked ➜ Locked | Locked | Oct 14 2024 |
| Keybanc | Locked ➜ Locked | Locked | Oct 11 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan: Locked ➜ Locked
|
Dec 03 2024 |
|
Locked
RBC Capital: Locked ➜ Locked
|
Nov 20 2024 |
|
Locked
Macquarie: Locked ➜ Locked
|
Nov 19 2024 |
|
Locked
Macquarie: Locked ➜ Locked
|
Nov 13 2024 |
|
Locked
Macquarie: Locked ➜ Locked
|
Nov 04 2024 |
|
Locked
UBS: Locked ➜ Locked
|
Oct 14 2024 |
|
Locked
Keybanc: Locked ➜ Locked
|
Oct 11 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
